Table 1—

Baseline demographics and characteristics of the study population

CharacteristicInsulin glargine plus OADsPremixed insulin
n177187
Male/female (%)61/3957/43
Age (years)60.9 ± 8.760.4 ± 9.1
Weight (kg)85.1 ± 14.784.6 ± 14.2
BMI (kg/m2)29.5 ± 3.629.6 ± 3.6
Duration of diabetes (years)9.9 ± 7.39.9 ± 6.4
Duration of OAD treatment (years)7.0 ± 5.87.3 ± 5.5
C-peptide (ng/ml)3.5 ± 2.13.5 ± 2.1
HbA1c (%)8.85 ± 0.988.83 ± 0.87
FBG (mg/dl)171 ± 35172 ± 38
FBG (mmol/l)9.5 ± 1.99.6 ± 2.1
  • Data are means ± SD unless otherwise indicated. OAD refers to sulfonylurea plus metformin.